Dr. Mita Manna reports live from SABCS 2025, highlighting major advances across HER2+ and HR+ metastatic disease, as well as new adjuvant SERD data. She discusses how these findings may influence treatment decisions in Canada and upcoming REAL Alliance guidance.
